# Analgesic Nephropathy Pathology > Analgesic nephropathy for MBBS Pathology: phenacetin-era chronic interstitial nephritis, papillary necrosis, CT bumpy contours and urothelial cancer risk. - Canonical URL: https://prepelephant.com/topics/mbbs/pathology/analgesic-nephropathy-pathology - Exam / course: MBBS · Subject: Pathology - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Analgesic Nephropathy Pathology", PrepElephant, https://prepelephant.com/topics/mbbs/pathology/analgesic-nephropathy-pathology ## Direct answer Years of daily consumption of compound analgesic mixtures — classically phenacetin combined with aspirin and caffeine — slowly destroy the renal medulla, producing analgesic nephropathy: chronic tubulointerstitial nephritis with renal papillary necrosis and a characteristic computed tomography picture of bilaterally small kidneys with bumpy contours and papillary calcifications. Phenacetin has been banned across most of the world, including India, so the classic disease has become rare, but heavy long-term self-medication with non-steroidal anti-inflammatory drugs reproduces much of the same injury. Patients present insidiously with nocturia, sterile pyuria, anaemia, urinary tract infections and episodes of papillary sloughing causing colic or obstruction, and — the point examiners weight most — they carry a lasting increased risk of urothelial carcinoma of the renal pelvis and ureter requiring surveillance. ## What you must remember - **The culprit formulation:** phenacetin-containing compound mixtures taken daily for years, in cumulative doses measured in kilograms; single-agent paracetamol (its active metabolite) in ordinary doses is substantially safer, a distinction worth stating precisely. - **Mechanistic target:** the medulla concentrates analgesics and their reactive metabolites via the countercurrent system while running on a low oxygen budget; capillary sclerosis of the vasa recta adds ischaemia, so the papilla necroses first and the cortex scars second. - **The CT signature:** bilateral small kidneys, bumpy or undulating contours, and papillary calcifications — a combination essentially diagnostic in the right clinical setting and far more specific than ultrasound. - **Clinical clues:** an older patient (historically women with headache or arthritis) with nocturia, mild proteinuria, sterile pyuria, hypertension, anaemia and slowly rising creatinine; sloughed papillae cause haematuria, ureteric colic or acute obstruction. - **Histology:** chronic interstitial nephritis with tubular atrophy and fibrosis surrounding necrotic, sometimes calcified papillae; the cortex shows secondary atrophic change. - **The oncogenic legacy:** increased risk of transitional cell carcinoma of the upper tract, which may appear years after the analgesic habit stops — haematuria in these patients is never dismissed, and long-term follow-up is advised. - **Indian context:** over-the-counter access to non-steroidal anti-inflammatory drug combinations and self-medication culture make the modern equivalent relevant, even though phenacetin itself is banned; chronic kidney disease hotspots in coastal Andhra Pradesh and Odisha have been linked in reports to analgesic overuse alongside other factors, a point worth hedging rather than overclaiming. ## Why the papilla dies first The anatomy of the medulla explains the lesion without any memorisation. Blood arrives by descending vasa recta after the cortical glomeruli have taken their share, arriving hypoxic; the countercurrent multiplier makes the milieu hypertonic and slow-flowing; and urinary concentrating mechanisms deposit whatever the tubule reabsorbs — including conjugated phenacetin metabolites — at their highest concentration in the papillary tip. There, reactive quinone-imine species deplete glutathione exactly where replacement is slowest. Add aspirin-triggered prostaglandin inhibition, which removes the vasodilator protection of the medullary microcirculation, and the papilla tips into coagulative necrosis. The cortex then fails by subscription: obstructed and atrophic tubules downstream of necrotic papillae, interstitial fibrosis marching outward, and a shrunken, scarred kidney whose surface contour becomes bumpy as segments over dead papillae collapse. This is why the CT contour sign exists — the cortex sinks into the necrotic medullary segments, and the kidney looks gnawed. ## Where the exam sets its traps The first trap is the agent: examiners ask "which analgesic causes papillary necrosis?" expecting phenacetin (or its metabolite paracetamol in combination), and candidates lose the mark by blurting "aspirin" alone. The second is the double life of papillary necrosis — diabetes and sickle disease cause it far more often in Indian practice, so analgesic nephropathy is a diagnosis of a compatible imaging signature plus a drug history taken patiently, sometimes with the old tablets produced from a handbag. The third is the follow-up obligation: a patient who stopped analgesics ten years ago and now has painless haematuria needs urothelial malignancy excluded first, because the carcinogenic debt persists after the renal one has been paid. ## Frequently asked questions ### Which analgesic classically causes analgesic nephropathy? Phenacetin, especially in compound mixtures with aspirin and caffeine taken daily for years; phenacetin has been banned in most countries including India. ### What computed tomography findings suggest analgesic nephropathy? Bilaterally shrunken kidneys with bumpy contours and papillary calcifications — a highly suggestive combination in a patient with a compatible drug history. ### Why does the renal papilla bear the brunt of the injury? The medulla concentrates analgesic metabolites through the countercurrent system while being relatively hypoxic and dependent on prostaglandin-mediated blood flow, so toxic and ischaemic injury converge there. ### What malignancy risk follows analgesic nephropathy? Urothelial carcinoma of the renal pelvis and ureter, with risk persisting years after analgesic withdrawal, so surveillance for haematuria is recommended. ### How is analgesic nephropathy managed? Complete withdrawal of compound analgesics and non-steroidal anti-inflammatory drugs, control of blood pressure, management of infections and obstruction, and long-term follow-up of renal function and urine cytology.